Speechmatics (United Kingdom)

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

Leszek K. Borysiewicz, Alison Fiander, M. Nimako et al. · The Lancet · 1996 · 530 citations

Vaccination, Cervical Cancer, Human Papillomavirus Vaccines +9

Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity

Andrew D. Weinberg, Martin-Muy Rivera, Rodney A. Prell et al. · The Journal of Immunology · 2000 · 385 citations · Full text

Pervasive Defaunation of Forest Remnants in a Tropical Biodiversity Hotspot

Gustavo Rodrigues Canale, Carlos A. Peres, Carlos Eduardo Guidorizzi et al. · PLoS ONE · 2012 · 267 citations · Full text

The Fair and Equitable Treatment Standard in International Investment Law and Practice

Stephen Vasciannie · British Yearbook of International Law · 2000 · 186 citations

Public Policy, Comparative Law, International Finance +14

Regulation of T Cell Activation In Vitro and In Vivo by Targeting the OX40-OX40 Ligand Interaction: Amelioration of Ongoing Inflammatory Bowel Disease with an OX40-IgG Fusion Protein, But Not with an OX40 Ligand-IgG Fusion Protein

Lisa M. Higgins, Stuart A.C. McDonald, Nigel Whittle et al. · The Journal of Immunology · 1999 · 169 citations · Full text